Last reviewed · How we verify
Ioxitalamate (IOXITALAMIC ACID)
At a glance
| Generic name | IOXITALAMIC ACID |
|---|---|
| Drug class | ioxitalamic acid |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Feasibility and Safety of an Ileus Management Protocol for Postoperative Ileus After Abdominal Surgery (NA)
- Computed Tomography Vs. Endoscopy Study
- Impact of Oral Contrast in the Large Intestine on the Recognition of Appendix (NA)
- Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy (NA)
- Improvement of Appendix Identification and Appendicitis Diagnosis in us After Administration of Oral Contrast Medium (NA)
- Comparative Analysis of Intra-articular Injection of Steroid and/or Sodium Hyaluronate in Adhesive Capsulitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ioxitalamate CI brief — competitive landscape report
- Ioxitalamate updates RSS · CI watch RSS